A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery (Q28241622)
Jump to navigation
Jump to search
scientific article (publication date: 2004)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery |
scientific article (publication date: 2004) |
Statements
A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery (English)
0 references
January 2004
0 references
127
0 references
1
0 references
79-86
0 references